Biocompatible: A modular chemoenzymatic synthesis (see scheme) based on asymmetric organo- and biocatalytic reaction sequences allows the sequential construction of both stereogenic centers of 1,3-diols and leads to all four possible stereoisomers in enantiomerically pure form. The biocompatibility of the organocatalytic aldol reaction allows its direct use in the subsequent enzymatic reduction without the need for a work-up step.
No takes yet. Share an insight, caveat, or question.
Baer et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: